Medicamentos de Canadá que empiezan por ir

Elija la primera letra del medicamento

2 3 4 6 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Elija la segunda letra del medicamento

ib ic id if ig il im in io ip ir is it ix

Resultados

IRBESARTAN HCT SIVEM film-coated tablet 150 mg+12.5 mg

Sivem Pharmaceuticals ULC

IRBESARTAN HCT SIVEM film-coated tablet 300 mg+12.5 mg

Sivem Pharmaceuticals ULC

IRBESARTAN HCT SIVEM film-coated tablet 300 mg+25 mg

Sivem Pharmaceuticals ULC

IRBESARTAN HCTZ PRO DOC film-coated tablet 150 mg+12.5 mg

Pro Doc Limitée

IRBESARTAN HCTZ PRO DOC film-coated tablet 300 mg+12.5 mg

Pro Doc Limitée

IRBESARTAN HCTZ PRO DOC film-coated tablet 300 mg+25 mg

Pro Doc Limitée

IRBESARTAN HCTZ SANIS film-coated tablet 150 mg+12.5 mg

Sanis Health Inc

IRBESARTAN HCTZ SANIS film-coated tablet 300 mg+12.5 mg

Sanis Health Inc

IRBESARTAN HCTZ SANIS film-coated tablet 300 mg+25 mg

Sanis Health Inc

IRBESARTAN PRO DOC tablet 150 mg

Pro Doc Limitée

IRBESARTAN PRO DOC tablet 300 mg

Pro Doc Limitée

IRBESARTAN PRO DOC tablet 75 mg

Pro Doc Limitée

IRBESARTAN SANIS tablet 150 mg

Sanis Health Inc

IRBESARTAN SANIS tablet 300 mg

Sanis Health Inc

IRBESARTAN SANIS tablet 75 mg

Sanis Health Inc

IRBESARTAN SIVEM tablet 150 mg

Sivem Pharmaceuticals ULC

IRBESARTAN SIVEM tablet 300 mg

Sivem Pharmaceuticals ULC

IRBESARTAN SIVEM tablet 75 mg

Sivem Pharmaceuticals ULC

IRESSA film-coated tablet 250 mg

Astrazeneca Canada Inc

IRINOTECAN HOSPIRA concentrate for solution for infusion 20 mg/ml

Hospira Healthcare Corporation

IRINOTECAN HYDROCHLORIDE TRIHYDRATE ACCORD concentrate for solution for infusion 100 mg/5 ml

Accord Healthcare Inc

IRINOTECAN HYDROCHLORIDE TRIHYDRATE ACCORD concentrate for solution for infusion 40 mg/2 ml

Accord Healthcare Inc

IRINOTECAN HYDROCHLORIDE TRIHYDRATE ACCORD concentrate for solution for infusion 50 mg/25 ml

Accord Healthcare Inc

IRINOTECAN HYDROCHLORIDE TRIHYDRATE SANDOZ concentrate for solution for infusion 20 mg/ml

Sandoz Canada Incorporated

IRINOTECAN PFIZER concentrate for solution for infusion 100 mg/5 ml

Pfizer Canada Inc

IRINOTECAN PFIZER concentrate for solution for infusion 300 mg/15 ml

Pfizer Canada Inc

IRINOTECAN PFIZER concentrate for solution for infusion 40 mg/2 ml

Pfizer Canada Inc

IRINOTECAN PHARMACEUTICAL concentrate for solution for infusion 100 mg/5 ml

Pharmaceutical Partners of Canada Inc

IRINOTECAN PHARMACEUTICAL concentrate for solution for infusion 300 mg/15 ml

Pharmaceutical Partners of Canada Inc

IRINOTECAN PHARMACEUTICAL concentrate for solution for infusion 40 mg/2 ml

Pharmaceutical Partners of Canada Inc

IRINOTECAN PHARMACEUTICAL concentrate for solution for infusion 500 mg/25 ml

Pharmaceutical Partners of Canada Inc

IRINOTECAN TEVA concentrate for solution for infusion 100 mg/5 ml

Teva Canada Limited

IRINOTECAN TEVA concentrate for solution for infusion 40 mg/2 ml

Teva Canada Limited

IRINOTECAN TEVA concentrate for solution for infusion 500 mg/25 ml

Teva Canada Limited

© 2026. Vidal Vademecum Spain, S.A. | Cochabamba, 24. 28016 Madrid, España - Tel. 91 579 98 00 - Fax: 91 579 82 29
Vademecum.es está reconocido oficialmente por las autoridades sanitarias correspondientes como Soporte Válido para incluir publicidad de medicamentos o especialidades farmacéuticas de prescripción dirigida a los profesionales sanitarios (S.V.nº09/10-W-CM), concedida el 3 de diciembre de 2010.

Aviso: La información que figura en esta página web está dirigida exclusivamente a profesionales facultados para prescribir o dispensar medicamentos, por lo que se requiere una formación especializada para su correcta interpretación.

© Vidal Vademecum Spain | Contacte con nosotros | Política de Privacidad | Aviso legal | Política de Cookies | Configurar preferencias Cookies